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contributing to atherosclerosis susceptibility in
the innominate artery
Jody Albright3, Pamela M Quizon3, Aldons J Lusis4,5,6 and Brian J Bennett1,2,3*Abstract
Background: Atherosclerosis, the underlying cause of cardiovascular disease, results from both genetic and
environmental factors.
Methods: In the current study we take a systems-based approach using weighted gene co-expression analysis to
identify a candidate pathway of genes related to atherosclerosis. Bioinformatic analyses are performed to identify
candidate genes and interactions and several novel genes are characterized using in-vitro studies.
Results: We identify 1 coexpression module associated with innominate artery atherosclerosis that is also enriched
for inflammatory and macrophage gene signatures. Using a series of bioinformatics analysis, we further prioritize
the genes in this pathway and identify Cd44 as a critical mediator of the atherosclerosis. We validate our predictions
generated by the network analysis using Cd44 knockout mice.
Conclusion: These results indicate that alterations in Cd44 expression mediate inflammation through a complex
transcriptional network involving a number of previously uncharacterized genes.
Keywords: Atherosclerosis, Co-expression network, inflammationBackground
Cardiovascular disease (CVD) is the leading cause of
death in the United States and the incidence of CVD is
rapidly increasing in other countries [1]. A common cause
of cardiovascular disease is atherosclerosis, a pathological
process resulting from an inflammatory response to lipids
deposited in the artery wall. Atherosclerosis is a highly
complex disease involving interactions among numerous
genetic and environmental factors [2]. Well established
risk factors for atherosclerosis include: gender, race,
dyslipidemia, diabetes and a family history of disease;
however these factors alone do not account for differences
in susceptibility to atherosclerosis. Based on human post-
mortem studies as well as experimental studies in model
organisms, it appears that these systemic risk factors* Correspondence: bennettb@email.unc.edu
1Department of Genetics, University of North Carolina, Chapel Hill, 500
Laureate Way, Suite 2303, Kannapolis, NC 28081, USA
2Department of Nutrition, University of North Carolina, Chapel Hill, NC 2808,
USA
Full list of author information is available at the end of the article
© 2014 Albright et al.; licensee BioMed Centra
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.act in part by affecting local inflammation in the vessel
wall [3-5].
Inflammation is a fundamental biological process that
provides protection from infection, but when dysregulated,
acts as a source of chronic disease. In particular, there has
been considerable interest in the role of inflammation in
the etiology of atherosclerosis [6,7] and improving our
understanding of how inflammatory pathways affect
atherosclerosis may identify new therapeutic targets.
Unfortunately, understanding how to regulate the immune
system to reduce chronic disease- associated inflammation
has been difficult. Monocyte-derived cells, such as macro-
phages and dendritic cells, are critical to immune system
function and are intimately involved in atherosclerosis
[8-10]. These cells along with lymphocytes are found at
sites of inflammation and within atherosclerotic lesions
[11]. Macrophages are of particular interest because
macrophage deficiency prevents atherosclerotic lesion
formation in mice [12,13] and because macrophage emi-
gration from lesions leads to reduced lesion size [14].
Thus, identification of pathways that regulate vascularl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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novel therapeutic targets.
We previously published Quantitative Trait Locus
(QTL) studies that identified a novel locus controlling
innominate artery (IA) lesion size, with a 95% confidence
interval spanning 14 Mb on Chromosome 2. These studies
used F2 progeny from a genetic cross between C57BL6/J.
Apoe−/− mice, classically characterized as atherosclerosis
susceptible, and C3H/HeJ.Apoe−/− mice, classically charac-
terized as atherosclerosis resistant [15]. Surprisingly, this
QTL was not identified to regulate atherosclerosis in the
aortic sinus of mice from the same cross [16], indicating a
unique genetic contribution among various vascular sites.
Furthermore, the susceptible allele for this QTL was
derived from the C3H/HeJ mice, the strain historically
characterized as atherosclerosis resistant [16-18]. Among
the 360 genes within the QTL, we identified Cd44 as a
high probability candidate gene for this QTL based on its
physical location within the QTL boundary, the high
correlation between IA atherosclerosis and the mRNA
levels of Cd44, and prior reports of its role in atheroscler-
osis [19,20] and inflammation [21]. However, the gene(s)
within the QTL responsible for the increased atheroscler-
osis susceptibility and more importantly a mechanism for
the increased susceptibility remains unknown.
The primary objective of this study was to identify novel
pathways and mechanisms contributing to innominate ar-
tery atherosclerosis. Using Weighted Gene Co-Expression
Network Analysis (WGCNA) we identify a module (group)
of highly related transcripts, correlated with IA lesion size.
This module is enriched with genes normally expressed in
macrophages suggesting either the influence of Kupfer cells
in the liver or general alteration of tissue macrophage
response to atherosclerotic stimuli. We characterize the
expression of several of the genes in this module through
cell culture experiments using primary macrophages.
Causal modeling using Network Edge Orienting analysis
confirm Cd44 as a likely causal gene within this pathway.
We also identify several key genes within the module that
are sensitive to altered Cd44 expression and likely to affect
atherosclerosis risk.
Methods
Quantitative trait locus studies
QTL results have been previously reported [15]. In brief,
C57BL/6J.Apoe−/− mice were purchased from The Jackson
Laboratory and C3H/HeJ.Apoe−/− mice were bred by
backcrossing B6.Apoe−/− to C3H/HeJ for 10 generations.
F2 mice (BxH Apoe−/−) were generated by crossing B6.
Apoe−/− with C3H.Apoe−/− and subsequently intercross-
ing the F1 mice as described [16]. The F2 mice (n = 86)
mice were fed a Western diet (Teklad 88137) containing
42% fat and 0.15% cholesterol for 16 weeks until eu-
thanasia and innominate artery phenotyping at 24 weeksof age. A genetic map with markers about 1.5 cM apart
was constructed using SNP markers as described [16].
RNA was isolated from tissues of the F2 mice using Trizol
and microarray analysis was performed on the RNA using
60mer oligonucleotide chips (Agilent Technologies) as
previously described [22]. Expression data can be obtained
from GEO databases for liver (GSE2814).Weighted gene co-expression network analysis
Network analysis was performed using the WGCNA R
package [23]. An extensive overview of WGCNA, including
numerous tutorials, can be found at http://labs.genetics.ucla.
edu/horvath/CoexpressionNetwork/Rpackages/WGCNA/
and this method has been extensively used to create co-
expression networks [23-28]. To begin, we filtered the array
data to include 8173 probes expressed in the liver as
previously described [29]. To generate a co-expression
network for the selected probes, an adjacency matrix is
created by first calculating the pairwise gene:gene correla-
tions for all 8173 probes and then raising the Pearson
correlation to the 8th power. The power was selected using
the scale-free topology criterion, which is determined by
the function “pickSoftThreshold” in the WGCNA package
[23,30]. Network connectivity (k.total) of the genes was
calculated as the sum of the connection strengths with all
other network genes. A TOM-based dissimilarity measure
was used for hierarchical clustering of the genes. Gene
modules corresponded to the branches of the resulting
dendogram and were defined using the “Dynamic Hybrid”
branch cutting algorithm [31]. The parameters for module
generation were as follows: “cut height” parameter was set
to 0.97 and the “minimum module size” parameter was set
to 50. Gene significance (GS) for each gene was determined
and is defined as the correlation between innominate
artery atherosclerosis and expression of probes. Module
significance (MS) was calculated as the mean GS for all
module genes. Module eigengenes were defined as the
first principal component calculated using PCA. Overall
network visualization and sub-networks were visualized
using Cytoscape [32].Gene ontology
We performed a Gene Ontology (GO) enrichment ana-
lysis for network modules using the Database for
Annotation, Visualization and Integrated Discovery
(DAVID) using the functional annotation clustering
option [33]. Functional annotation clustering combines
single categories with a significant overlap in gene con-
tent and then assigns an enrichment score (ES; defined
as the –log10 of the geometric mean of the unadjusted
P-values for each single term in the cluster) to each
cluster.
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Causal relationships were identified using Network edge
orienting (NEO) as previously described [34]. An R pack-
age is available at http://labs.genetics.ucla.edu/horvath/
aten/NEO/ and assigns direction to the edges of a network
using structural equation models that integrate genetic
markers, gene expression levels and clinical traits. NEO
estimates the probability of 3 models: causal, reactive and
independent. We restricted the analyses to the peak
marker of the Chr 2 QTL for innominate artery athero-
sclerosis, individual gene expression levels for genes in
the brown module, and size of innominate artery athero-
sclerosis. We used the single marker analysis function of
NEO (LEO.NB.SingleMarker) score, which is the log10
probability of this model divided by the log10 probability
of the next best fitting alternative model [34]. LEO scores
in excess of 0.3 were set as a threshold of for further inves-
tigation as a value of 0.3 indicates that the causal model is
two times more likely, given the data, then the next best
model, similar to previous studies [24,35]. The Root Mean
Square Error of Approximation (RMSEA) is an index of
model fit and was used to evaluate the overall model fit
for NEO. RMSEA indices close to zero indicate good
model fit and a threshold of 0.05 was used as previously
suggested [34].
Cell culture studies
C57BL/6J, C3H/HeJ and Cd44−/− mice where purchased
from the Jackson Laboratory and bred at the David
Murdock Research Institute. Mice were handled in strict
accordance with the recommendations in the Guide for
the Care and Use of Laboratory Animals of the National
Institutes of Health under protocols approved by the
Institutional Animal Care and Use Committees of the
North Carolina Research Campus (Protocol Number:
12–003). Mouse peritoneal macrophages where isolated
from C57BL/6J, C3H/HeJ and CD44−/− four days after an
IP injection of thioglycolate as previously described [36].
Cells were washed with PBS, red blood cells lysed using
ACK lysis buffer, and the remaining counted and plated at
100,000 cells per cm2 into 12 well plates. Cells were grown
in DMEM (Hyclone, Logan, Utah) supplemented with
20% FBS (Hyclone, Logan, Utah) overnight, rinsed with
PBS and then adherent cells treated in 1% FBS alone as
a control or stimulated with LPS (List Biological Inc.,
Campbell, CA, #201). Cells were treated for 4 hours ex-
cept for time-course experiments. RNA was extracted
using a Maxwell instrument (Promega, Madison WI) and
RNA quality was assessed using an Experion Bioanalysis
system (BioRad, Hercules CA).
Real time PCR
Total RNA was isolated according to manufacturer’s spec-
ifications using Promega’s Maxwell 16 with the Maxwell16 Cell LEV Total RNA Purification Kit (Promega,
AS1225). cDNA was synthesized using Applied Biosystems
High Capacity cDNA Reverse Transcription Kit (Life
Technologies, 4368813). qPCR was done on a Roche
Lightcycler 480 II using Kapa SYBR FAST Master Mix
(KAPA, KK4609). Relative gene expression was determined
using an efficiency corrected method, and efficiency was
determined from a 3-log serial dilutions standard curve
made from cDNA pooled from all samples. Primers were
designed across exon-exon boundaries using Roche UPL
guidelines. Results were normalized to Rpl4.
Repository data
Publically available micro-array data (GEO10000), which
contained replicate samples of aortas from C57BL/6J
mice as well as Apoe−/− mice at 6 weeks and 36 weeks of
age was downloaded from gene expression omnibus. We
matched the genes in our network and this dataset by
Entrez gene IDs, and assigned probes to the correspond-
ing module. We examined the expression of our candidate
genes in human endarterectomy samples using publically
available micro-array data GSE43292. In brief, carotid
endarterectomy collected in 32 hypertensive patients. The
samples contained media and neo-intima without ad-
ventitia. They were paired, including for each patient
one sample of the atheroma plaque (stage IV and over
of the Stary classification [37]) containing core and shoul-
ders of the plaque, and one sample of distant macroscop-
ically intact tissue (stages I and II).
Statistical analysis
Statistical analysis was performed using Prism Graphpad
software (V5.0). Comparison between control and treat-
ment group(s) was carried out using either a Student’s t
test or one-way ANOVA, and statistical significance is
shown as described in the figure legends.
Results
Transcriptional network analysis identifies pathway
contributing to atherosclerosis
QTL studies have demonstrated the genetic complexity of
atherosclerosis; however, actual identification of the causal
gene(s) underlying these QTL is difficult. The difficulty
validating candidate genes identified in QTL studies is pri-
marily due to the poor resolution of the approach, large
regions of chromosomes are identified and often contain
hundreds of genes [38]. For example, the novel locus on
Chromosome 2 controlling atherosclerosis development
in the IA contains 360 genes [15]. We used global hepatic
gene expression, from microarrays, and a network-based
approach to further interrogate the effect of this locus.
These expression data have previously been used to iden-
tify co-expressed genes regulating bodyweight and the
metabolic syndrome [39]. Our current study used a subset
Figure 2 Genetic network associated with innominate artery
atherosclerosis. Weighted Gene Co-expression analysis of liver RNA
identifies 10 modules of highly co-expressed genes. Networks are
visualized in Cytoscape. Note size of the module denotes the overall
connectivity of the hubs and strength of the topological overall is
denoted by the length of the edge.
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artery atherosclerosis, an artery that recapitulates human
atherosclerosis [40]. The current study uses a series of
analytical analyses and cell culture experiments to further
interrogate this locus and an overview of the analyses and
experiments is shown in Figure 1.
We constructed a co-expression network by grouping
the expression of genes in the liver based on their topolo-
gic overlap, using Weighted Gene Co-expression Network
Analysis (WGCNA) [23]. To perform the current analysis,
we selected 8173 probes representing 8023 unique genes
as previously described [22], from the microarray data.
We implemented WGCNA with stringent parameters
which resulted in 4485 genes being divided into 10 co-
expression modules (groups of co-expressed genes) while
the remaining 3538 genes were not able to form a module
and have not been further analyzed (Additional file 1:
Table S1). The hierarchical clustering of the genes into
modules is shown in Additional file 2: Figure S1 and the
topological overlap of the modules in Additional file 2:
Figure S2. The overall network structure was visualized in
Cytoscape [32] (Figure 2).
We next performed enrichment analysis using DAVID
[33] and found that eight of the 10 modules wereFigure 1 Overview of analysis: This flowchart presents a brief overview of the analysis and subsequent experiments performed.
1. Construction of the weighted gene Co-expression network Analysis and relationship to innominate artery atherosclerosis. 2. Relationships
between modules and atherosclerosis were confirmed using independent and publically available gene expression datasets. 3. Ontology
analysis was performed using DAVID and identified macrophages as a potential cell type for validation of the network. In-vitro experiments
are performed to characterize module genes. 4. Causality analysis is performed and experiments using macrophages from gene targeted mice
are used to validate predictions.
Albright et al. BMC Medical Genomics 2014, 7:51 Page 5 of 15
http://www.biomedcentral.com/1755-8794/7/51significantly enriched with genes representing specific
Gene Ontology (GO or Kyoto Encyclopedia of Genes
and Genomes (KEGG) classifications (Table 1). A list
of each gene contained in the 10 modules is provided in
Additional file 1: Table S1 and all enrichment categories for
the modules are provided in Additional file: 3 Table S2.
While the network was based on hepatic gene expression,
the Chr 2 locus was not associated with plasma lipid levels
[15]; Thus, we hypothesized that our network analysis
would identify novel, non-lipid mediated, pathways associ-
ated with lesion development. To determine which genes
and modules were related to lesion size, we calculated two
metrics, the Gene Significance (GS) and Module Signifi-
cance (MS). The GS is the absolute value of the correl-
ation (Pearson’s r) between the expression of each gene in
our network and the extent of lesion development in the
innominate artery [23] and is used to identify genes that
are related to lesion size. The MS is the mean GS for each
module [23] and is used to identify which modules are
most highly correlated with lesion size. To determine the
significance threshold for the MS metric we created 10000
sets of 400 GS values and calculated the correlation with
IA atherosclerosis. Using a 1-sided distribution of 0.95 we
found that a MS of 0.15 corresponds to a p < 0.05. From
this, we identified 3 modules that exceeded this threshold,
(brown, red and salmon Figure 3A), and so were signifi-
cantly related to IA lesion size.
We next hypothesized that our atherosclerosis-related
network modules should contain genes that are over-
represented in atherosclerotic tissue. To perform this
analysis we used publically available microarray data
(GEO10000), which contained replicate samples of aortas
from C57BL/6J mice as well as Apoe−/− mice at 6 weeksTable 1 Characterization of modules
Module number Module Number of
probes
Number of
unique genes
En
1 Black 726 711 IP
2 Blue 862 847 IP
C
3 Brown 666 655 G
p
4 Green- yellow 96 94 SP
5 Magenta 134 132 SP
6 Pink 173 167 SP
7 Purple 115 111 G
co
8 Red 315 315 n
9 Salmon 524 517 G
ex
10 Turquoise 946 936 G
re
No module Grey 3616 3538and 36 weeks of age. We matched the genes in our net-
work and this dataset by Entrez gene IDs, and assigned
probes to the corresponding module. Of the 4485 genes in
our network, this array contains 3992 genes, represented
by 8205 probes. These probes were assigned to the cor-
responding network modules and the fold change in
expression was calculated by subtracting the mean log2
expression values of the C57BL/6 J mice from mean
log2 expression values of the Apoe
−/− mice. At 6 weeks
of age, when lesion size was expected to be small, there
was no enrichment of any of module (Figure 3B). We
repeated this analysis at 36 weeks of age, a time when
IA lesion size was developed in the Apoe−/− mice, and
found that only 1 module, (the brown module), contained
significant enrichment of genes overexpressed in athero-
sclerotic tissues (Figure 3C). The co-expression pattern of
the Brown Module genes discussed in detail in the current
manuscript are shown in Figure 2D.
We again used DAVID [33], to search for tissues and
cell types in which these genes were over-represented
and found that the brown module is enriched for
genes expressed in activated spleen and macrophages
(p < 8.01×10−10 and p < 2×10−06, Bonferroni corrected)
Table 1. We confirmed the macrophage specificity of
this module by examining the enrichment of the core
macrophage signal recently identified by the Immuno-
logical Genome (ImmGen) Project [41]. Of the 39 genes
comprising the core macrophage transcriptional profile,
26 were assayed in our microarray studies and 13 were
enriched in the brown module (p < 3.3×10−11, Fisher’s
exact test). The enrichment of other modules was calcu-
lated using DAVID and is shown in Additional file 3:
Table S2.richment term Fold enrichment FDR
R001909:Krueppel-associated box 3.97 1.39×10−07
R017973:Cytochrome P450,
-terminal region
4.9 3.93×10−04
O:0001817 ~ regulation of cytokine
roduction
4.41 1.64×10−08
_PIR_KEYWORDS: protein transport 5.45 4.15×10−04
_PIR_KEYWORDS: protein transport 5.45 4.15×10−04
_PIR_KEYWORDS: methyltransferase 6.32 0.044
O:0030529 ~ ribonucleoprotein
mplex
5.29 0.012
one
O:0005578 ~ proteinaceous
tracellular matrix
3.1 2.32×10−06
O:0007186 ~ G-protein coupled
ceptor protein signaling pathway
2.3 8.39×10−10
D  Module Genes C 
Evl
Cd44
FERMT3
Plcg2
Gpsm3
Ncf2Trpv2
Apbb1ip
Was
Nckap1l
A Module Significance 
Aortic Tissue 36 weeks age 
B  Aortic Tissue 6 weeks age 
Figure 3 Co-expression Network analysis identifies the Brown module as related to Atherosclerosis. (A). Mean MS score for each of the
11 network modules. (B) Mean module gene expression in atherosclerotic aorta tissue relative to non-atherosclerotic tissue at 6 weeks. (C) Mean
module gene expression in atherosclerotic aorta tissue relative to non-atherosclerotic tissue at 36 weeks. In panels (B–C) expression is presented
as the mean log2 expression for each gene in a module in aorta from C57BL/6 J Apoe−/− mice minus log2 expression from wild type C57BL/6 J
mice. (D) A sub-network of co-expressed genes in the Brown Module including Cd44 and the brown module hub genes. Gene connectivity
determines size of each node. Distance between nodes is determined by the topological overlap. * denotes significant differences (p < 0.05).
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We next focused on identifying candidate genes in the
brown module that regulate the response to atherosclerotic
and inflammatory stimuli. Among the 655 genes in this
module, several criteria were used to identify candidate
genes. Our first criterion was to prioritize genes by their
connectivity because highly connected genes, also called
hub genes, have been previously shown to be key regulators
of the module [29,42,43]. In particular, connectivity and
GS are significantly correlated in the brown module
(Additional file 2: Figure S3), further indicating that
identifying highly connected genes will yield candidates
with a strong relationship to atherosclerosis. The most con-
nected genes in this module are: Nckap1l, Evl, Apbb1ip,
Fermt3, Ncf2, Trpv2, Gpsm3, Was, Plcg2 (Table 2). Ourpositional candidate, Cd44, was not a highly connected
gene ranking 362 out of the 666 genes in the module
(Additional file 1: Table S1).
Hub Gene Expression altered by inflammatory stimulus
Atherosclerotic lesions contain many cell types and the
over-representation of the brown module genes in mac-
rophages and activated spleen prompted us to attempt
to characterize the brown module genes using in vitro
systems. We first characterized expression of our key
brown module genes in thioglycolate-elicited peritoneal
macrophages in the basal state and treated with varying
amount of bacterial lipopolysaccharide (LPS). We used
Tnf expression as a positive control for these experiments
to demonstrate induction of an inflammatory response.
Table 2 Hub Genes in brown module
Gene symbol Gene name Chr Mb Kme Expression regulated
byChr 2: eQTL
Role in atherosclerosis Role in monocyte
derived cells
Known candidate for
human disease
Leo score RMSEA
Nckap1l (Hem-1) NCK associated protein 1 like 15 103 1 Yes (6.18) None Known Yes [44] None Known −1.22 0.255
105.89 Mb
Evl Ena-vasodilator stimulated
phosphoprotein
12 108 0.93 Yes (6.17) None Known None leukocyte adhesion
deficiency
−1.46 0. 280
84.17 Mb
Apbb1ip (RIAM) amyloid beta (A4) precursor
protein-binding, family
2 23 0.92 Yes (7.86) None Known Yes phagocytosis [45] None Known −21.27 0. 255
81.80 Mb
Fermt3 fermitin family homolog 3 19 7 0.88 Yes (7.73) None Known Yes [46] leukocyte adhesion
deficiency
−0.49 0.223
105.89 Mb
Ncf2 neutrophil cytosolic factor 2 1 153 0.85 Yes (4.23) None Known Yes [47] Chronic granulomatous
disease
−1.87 0.283
84.17 Mb
Trpv2 transient receptor potential
cation channel, subfamily V,
member 2
11 63 0.83 Yes (8.19) None Known Yes-cell death in
response to oxidized
LDL [48,49]
None Known −1.38 0.275
148.90 Mb
Gpsm3 G-protein signaling modulator 3 17 34 0.82 Yes (5.81) None Known Yes [50] None Known −1.76 0.28
105.89 Mb
Was Wiskott-Aldrich syndrome
homolog
X 8 0.81 none Yes [51] Wiskott-Aldrich syndrome −1.33 0.268
Plcg2 phospholipase C, gamma 2 8 117 0.80 Yes (7.38) None Known Yes [52,53] Familial cold autoinflammatory
syndrome
−0.98 0.254
105.89 Mb
Cd44 CD44 antigen 2 102 0.26 Yes Yes Yes None Known 1.01 0.000
Kme- is the weighted connectivity for the gene. LEO.NB, log10 ratio of causal model to all other model probabilities; −log10P, RMSEA, a model fit index (index close to 0 indicates good fit of the causal model).
A
lbright
et
al.BM
C
M
edicalG
enom
ics
2014,7:51
Page
7
of
15
http://w
w
w
.biom
edcentral.com
/1755-8794/7/51
Albright et al. BMC Medical Genomics 2014, 7:51 Page 8 of 15
http://www.biomedcentral.com/1755-8794/7/51We repeated these experiments with doses of LPS
between 2 and 200 ng/ml. We observed significant
induction of Apbb1ip, and Cd44 while Evl, Fermt3, Gpsm3
and Was were down-regulated by increasing amounts of
LPS (Additional file 2: Figure S4). We also examined the
time course response for the brown module genes for
treatment times ranging from 2 to 8 hours, and observed
that these genes are responsive to LPS in a time-dependent
manner (Additional file 2: Figure S5). These experiments
were also conducted in RAW 264.7 cells with similar
results (data not shown).
Hub gene expression varies by strain
The original QTL was found in a cross between C57BL/6 J
and C3H/HeJ mice. We therefore next sought to determine
expression level of our key candidate genes in peritoneal
macrophages from both of these strains with and without
the addition of 10 ng/ml LPS. We found that Apbb1ip,
Cd44, Evl, Fermt3, Gpsm3, Ncf2, Nckap1l, Plcg2, Trpv2, and
Was were differentially expressed between strains in un-
stimulated cells (Figure 4). As expected there was no re-
sponse in C3H/HeJ to LPS as these mice are defective in
Tlr4 signaling (Figure 4).
Characterizing transcriptional regulation of the brown
module
Our WGCNA analysis groups the genes by topological
overlap and develops an undirected network with a
module (Brown module) of highly connected genes that
is associated with innominate artery atherosclerosis. We
previously reported an expression QTL (eQTL) for Cd44
[41] and hypothesized that additional genes in the brown
module may be regulated by the Chr 2 locus in trans
(distant eQTL). Several of our hub genes Nckap1l, Fermt3,
Trpv2, Gpsm3 and Evl, have eQTL that map to the Chr 2
locus (distant eQTL) Table 2 and http://systems.genetics.
ucla.edu/data [54]. The existence of several distant eQTL
indicates that a common genetic variant at Chr 2 is regu-
lating the expression of these genes. However, we have not
assessed the relationship among the genes in the Brown
module nor how transcriptional changes to specific tran-
scripts may alter expression of the Brown module.
To better assess relationship between individual genes
in the Brown module and atherosclerosis, we utilized
Network Edge Orienting (NEO), a freely available R
package [34], to assess the causal relationships between
the peak SNP associated with IA lesion size, rs368994,
the hepatic expression of genes contained in the Brown
module and IA atherosclerosis. This analysis showed
that Cd44 had the highest LEO score indicating that it
is the brown module gene with the highest likelihood
of a causal relationship with atherosclerosis (Table 2). No
other genes in the Brown module had a significant LEO
score indicating that differences in Cd44 expression areproximal to atherosclerosis as compared to the remaining
Brown module Genes. Thus, we hypothesized that pertur-
bations in Cd44 expression may affect the gene expression
of genes within the Brown module.
To investigate the role of Cd44 on the expression of
these module genes, we isolated thioglycolate-elicited
peritoneal macrophages from Cd44−/− and wild-type
mice, on a C57BL/6J mice genetic background, and
performed qPCR. We first compared the expression of
the Brown module genes in unstimulated macrophages
and observed small but statistically significant differences in
Fermt3, Gpsm3 Nckap1l, and Plcg2. We also determined
the response to LPS in both Cd44−/− and WT macrophages
and observed significant differences in Cd44, Fermt3, Trpv2
and Was in response to LPS (Figure 5). These results
indicate that Cd44 expression is upstream of the Brown
module hub genes and is altering expression of these
genes.
We next sought to use NEO to identify which of the
module genes are directly downstream of Cd44. Thus,
we repeated our NEO analysis with hepatic Cd44 ex-
pression as the trait of interest. We used a LEO score of
0.3 as a threshold and predicted that 233 in the brown
module genes are downstream of Cd44. Interestingly, of
the 9 Hub genes, only Fermt3, Trpv2 and Plcg2 were
predicted to be directly downstream of Cd44, indicating
the effects of Cd44 on the remaining 3 hub genes that
are differentially expressed in Cd44−/− macrophages are
mediated by additional module members. In an attempt
to further characterize the Brown module genes that
may be responding to alterations in Cd44, we focused
on validating the 9 additional genes with the highest
LEO score (Table 3). To do so we first performed qPCR
for the key module genes on thioglycolate-elicited peri-
toneal macrophages from Cd44−/− and Cd44+/+ mice.
We compared the expression of the brown module
genes in unstimulated macrophages and observed small
but statistically significant differences in Kcng2, Dapp1,
Neurl2, Fmnl2, Calhm2, Ehd4, and Pltp, between Cd44
and WT macrophages (Figure 6).
Network genes are differentially expressed in human
atherosclerotic lesions
To better understand the overall translation of module to
human atherosclerosis, we next sought to determine the
expression of the module hub genes in human atheroscler-
otic tissue. We queried the Gene Expression Omnibus and
identified GSE43292, a dataset where 32 hypertensive
patients were treated for carotid atherosclerosis by endar-
tectomy. The tissue from the patients was excised and
advanced atherosclerotic tissue was compared to adjacent
tissue without macroscopic evidence of atherosclerosis
and both biopsies were subjected to expression array
analysis. In this case all of our identified hub genes were
Figure 4 Strain specific expression of hub genes. Peritoneal macrophages were isolated from C57BL/6 J and C3H/HeJ mice and treated in
triplicate with media or media with 10 ng/ml LPS for 4 hours. Expression of Apbb1ip, Cd44, Evl, Fermt3, Gpsm3, Ncf2, Nckap1l, Plcg2, Tnf, Trpv2, and
Was were normalized to Rpl4 and expressed relative to non-stimulated cells (Panels A-K respectively). * indicates significant differences P < 0.05.
Values represent mean ± sem.
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normal tissue (Figure 7). There was no significant differ-
ence in Cd44 expression between the macroscopically
intact tissue and atherosclerotic tissue.
Discussion
In the present study we use a network-based approach
to interrogate the atherosclerosis susceptibility of the
innominate artery. We identify 1 module that is highly
related to IA atherosclerosis using liver tissue from a
BxH Apoe−/− genetic intercross in which we identified a
major locus for IA atherosclerosis. This module is highly
enriched for immune-related genes, in particular those
of the monocyte/macrophage lineage. Overall, these
studies have resulted in four main findings. First, we
confirm that genes in this module are overexpressed in
atherosclerotic tissue using publically available microarray
data. Second, we demonstrate that the most connectedgenes in the module, “hub genes”, are differentially
expressed in macrophages stimulated with LPS and
between macrophages derived from C57BL/6J and C3H/
HeJ mouse strains. Third, using structural equation mod-
eling we predict that Cd44 as the most likely candidate
gene for our previously reported QTL and identify several
genes predicted to be downstream of Cd44. Lastly, we
validate novel interactions among the module genes
using macrophages isolated from Cd44−/− mice. Each of
these findings is discussed below.
Our network analysis identified a module that was
highly related to atherosclerosis in the IA and this module
was highly enriched for genes in activated macrophages
and spleen. Using freely available data at NCBI’s Gene
Omnibus, we were able to confirm that the genes located
in the brown module are significantly upregulated in
the aorta of Apoe−/− mice compared to age matched
C57BL/6J mice. These results demonstrate that genetic
Table 3 Genes predicted responsive to Cd44
Gene symbol Gene name Chr Mb Leo score % change Cd44−/−
basal (P-value)
Kcng2 Potassium voltage-gated channel, subfamily G, member 2 18 80 3.1 NS
Dapp1 Dual adaptor for phosphotyrosine and 3-phosphoinositides 1 3 137 3.08 10% (0.05)
Neurl2 Neuralized-like 2 (Drosophila) 2 164 2.99 30% (0.005)
Fmnl2 Formin-like 2 2 52 2.96 17% (0.002)
Calhm2 Calcium homeostasis modulator 2 19 47 2.7 12% (0.03)
Ehd4 EH-domain containing 4 2 120 2.67 10% (0.008)
Pltp Phospholipid transfer protein 2 164 2.61 18% (0.003)
Tex14 Testis expressed gene 14 11 87 2.52 −30% (0.02)
Vsig4 V-set and immunoglobulin domain containing 4 X 96 2.5 20% (0.03)
Figure 5 Cd44 modulates brown module hub gene expression. Peritoneal macrophages were isolated from C57BL/6 J and Cd44−/− mice and
treated in triplicate with media or media with 10 ng/ml LPS for 4 hours. Expression of Apbb1ip, Cd44, Evl, Fermt3, Gpsm3, Ncf2, Nckap1l, Plcg2, Tnf,
Trpv2, and Was were normalized to Rpl4 and expressed relative to non-stimulated cells from C57BL/6 J mice (Panels A-K respectively). Genotype
of the cells and treatment condition are indicated below the x-axis * indicates significant differences P < 0.05. Values represent mean ± sem.
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Figure 6 Confirmation of novel Cd44 target genes. Peritoneal macrophages were isolated from C57BL/6 J and Cd44−/− mice and treated in
triplicate with media or media with 10 ug/ml LPS for 4 hours. Expression of Calhm2, Dapp1, Ehd4, Fmnl2, Kcng2, Neurl2, Pltp, Tex14, and Vsig4 were
normalized to Rpl4 and expressed relative to non-stimulated cells (Panels A-H respectively). * indicates significant differences P < 0.05. Values
represent mean ± sem.
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http://www.biomedcentral.com/1755-8794/7/51networks identified in peripheral tissues, such as the liver,
are able to identify biologically meaningful signals with
relevance to disease.
None of the hub genes identified in the brown module
have been previously linked to atherosclerosis. However,
several of them are known to be involved in inflammation.
For example, Nckap1l, also known as Hem1, was recently
found to be an actin regulatory protein that interacts with
Was, another of the hub genes in the brown module. Was
has previously been shown to underlie Wiskott-Aldrich
syndrome which is characterized by defective clotting and
immune function and although Was has not been previ-
ously identified as a candidate gene for atherosclerosis, al-
tered clotting function and immune function are thought
to contribute to atherosclerotic lesion development. Ncf2
is a causal gene for chronic granulomatous disease, whilemutations in Fermt3 lead to leukocyte adhesion deficiency,
type 3. These data, along with reports of altered immune
function in Cd44−/− mice [21], indicate that interactions
among these genes may affect atherosclerosis susceptibil-
ity and that this genetic pathway involves alterations in
immune function.
In order to better understand how these genes respond
to atherosclerosis related inflammatory signals, we stimu-
lated peritoneal macrophages with LPS. These results indi-
cated that the expression of several of these genes is
significantly altered upon LPS stimulation. Furthermore,
the expression of these differed between the strains of the
original cross (C3H/HeJ and C57BL/6J). Together these
results support our predicted genetic network. One poten-
tial difference between the original QTL study and the
current network analysis and transcriptional validation
Figure 7 Brown Module Hub Genes are differentially expressed in human atherosclerosis. Publically available microarray data, GSE43292,
was analyzed for differential expression of brown module hub genes, Apbb1ip, Cd44, Evl, Fermt3, Gpsm3, Ncf2, Nckap1l, Plcg2, Tnf, and Trpv2.
Expression levels determined by robust multi-array normalization (RMA) for atherosclerotic sample (grey) and matched intact samples from the
patients (white). * indicates significant differences P < 0.05. Values represent mean ± sem.
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of the mice. The original QTL was identified in hyper-
lipidemic Apoe−/− mice which were originally developed
to elevate lipids and sensitize them to atherosclerosis
development [55] and several groups have used mice car-
rying this sensitizing mutation to identify QTL in mice
[16,18,56,57]. We decided to use C3H/HeJ and C57BL/6J
mice without the Apoe−/− mutation based on the fact that
the Chr 2 locus was independent of genetic signals for
plasma lipids.
Our co-expression network is undirected and thus we
cannot easily differentiate between causal and reactive
genes for atherosclerosis in the brown module. Consid-
ering the known QTL for IA atherosclerosis on Chr 2
[15], we focused on genes which were located within the
QTL boundary, and also present in the brown module.
Only 11 genes of the Brown module genes are located
within the 95% CI of the IA lesion size QTL (Additional
file 3: Table S3). Our initial candidate gene highlighted
in our previous publication was Cd44 but we were unable
to rule out the other 11 genes which reside in the QTL
boundary, nor could we use the differential expression
analysis to identify a single gene as 5 of the 11 genes
located at the Chr 2 QTL and in the Brown module aredifferentially expressed in atherosclerotic tissue (Cd44,
Pamr1, Nusap1, Mertk, and Ehd4).
Thus, we sought to use a bioinformatics approach
called network edge orienting, which incorporates geno-
type data and structural equation modeling to determine
causal genes within a gene list. The underlying approach
has been validated for lipids and bone mineral density
[24,35,43]. For this analysis we used all 666 brown module
genes and found that only 1 gene, Cd44, was predicted
to drive susceptibility to atherosclerosis. Therefore, we
focused several experiments on understanding how Cd44
may regulate expression of genes within brown module.
To identify potential novel targets of Cd44 within the
brown module we used two approaches. First we identi-
fied which of the hub genes had an eQTL mapping to the
atherosclerosis locus on Chr 2. The second approach
repeated our NEO analysis using Cd44 transcript levels as
our phenotype of interest and the peak SNP for the
atherosclerosis QTL, rs3671635, to anchor the analysis.
Using these approaches we identified genes that are likely
to be downstream of Cd44. To confirm these relationships
we used peritoneal macrophages from Cd44−/− mice and
determined that expression of our predicted genes is in-
deed, modulated in part by Cd44. Thus, all of our genes
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http://www.biomedcentral.com/1755-8794/7/51with eQTL mapping to the atherosclerosis QTL interval
in trans, Nckap1l, Fermt3, Trpv2, Gpsm3 and Evl, were
differentially expressed in Cd44−/− mice. In addition to
these genetic candidates, our NEO analysis identified over
100 genes in the module that are predicted to respond to
Cd44. We tested 9 of these and confirmed that 8 of these
are in fact reactive to Cd44 expression levels.
Finally, we demonstrated that the brown module hub
genes highlighted in this report are differentially expressed
in human atherosclerotic tissue suggesting that the mod-
ule of genes originally identified in the livers of athero-
sclerotic mice through gene co-expression analysis may,
in fact, have a direct role in the development and progres-
sion of atherosclerosis. Interestingly, CD44 was highly
expressed in both the atherosclerotic and macroscopically
intact adjacent tissue from humans and could indicate an
important difference in the regulation of atherosclerosis in
humans and mice. Alternatively, the lack of differential ex-
pression in the human tissues may reflect a high level of
local vascular inflammation in the macroscopically intact
tissues. This interpretation is supported by studies that in-
dicate that Cd44 is an early mediator of atherosclerosis
[58] and is upregulated by pro-atherosclerotic cytokines
[59]. Additional, studies are needed to clarify the role of
CD44 in atherosclerosis and differences between humans
and mice in CD44’s role in regulating in the inflammatory
response.
Conclusion
We were able to identify 1 module of co-expressed
genes that are related to atherosclerosis. This module
contains our putative candidate gene and through a series
of bioinformatics approaches we identify a potential
mechanism for this QTL, through altered macrophage
gene expression. None of these candidates has been
previously identified as involved in atherosclerosis and
thus represent novel targets for further investigation.
Together these data demonstrate the utility of a network
approach to prioritize genetic candidates and to identify
potential mechanisms for candidate genes identified in
QTL studies.
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